Literature DB >> 15760092

Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation.

Brijesh S Dave1, Avani F Amin, Madhabhai M Patel.   

Abstract

The purpose of this research was to prepare a gastroretentive drug delivery system of ranitidine hydrochloride. Guar gum, xanthan gum, and hydroxypropyl methylcellulose were evaluated for gel-forming properties. Sodium bicarbonate was incorporated as a gas-generating agent. The effects of citric acid and stearic acid on drug release profile and floating properties were investigated. The addition of stearic acid reduces the drug dissolution due to its hydrophobic nature. A 3(2) full factorial design was applied to systemically optimize the drug release profile. The amounts of citric acid anhydrous (X1) and stearic acid (X2) were selected as independent variables. The times required for 50% (t50) and 80% drug dissolution (t80), and the similarity factor f2 were selected as dependent variables. The results of the full factorial design indicated that a low amount of citric acid and a high amount of stearic acid favors sustained release of ranitidine hydrochloride from a gastroretentive formulation. A theoretical dissolution profile was generated using pharmacokinetic parameters of ranitidine hydrochloride. The similarity factor f2 was applied between the factorial design batches and the theoretical dissolution profile. No significant difference was observed between the desired release profile and batches F2, F3, F6, and F9. Batch F9 showed the highest f2 (f2 = 75) among all the batches, and this similarity is also reflected in t50 (approximately 214 minutes) and t80 (approximately 537 minutes) values. These studies indicate that the proper balance between a release rate enhancer and a release rate retardant can produce a drug dissolution profile similar to a theoretical dissolution profile.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760092      PMCID: PMC2750469          DOI: 10.1208/pt050234

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

1.  Colonic metabolism of ranitidine: implications for its delivery and absorption.

Authors:  A W Basit; L F Lacey
Journal:  Int J Pharm       Date:  2001-10-04       Impact factor: 5.875

2.  Ranitidine HCl: tablet film coating acidity and discoloration.

Authors:  R Eyjolfsson
Journal:  Drug Dev Ind Pharm       Date:  2000-06       Impact factor: 3.225

3.  On methods of expressing dissolution rate data.

Authors:  J A Goldsmith; N Randall; S D Ross
Journal:  J Pharm Pharmacol       Date:  1978-06       Impact factor: 3.765

4.  Drug/polymer matrix swelling and dissolution.

Authors:  R S Harland; A Gazzaniga; M E Sangalli; P Colombo; N A Peppas
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

5.  Influence of shape factors on kinetics of drug release from matrix tablets. II. Experimental.

Authors:  J Cobby; M Mayersohn; G C Walker
Journal:  J Pharm Sci       Date:  1974-05       Impact factor: 3.534

6.  Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules.

Authors:  J G Wagner
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

7.  Analysis of Fickian and non-Fickian drug release from polymers.

Authors:  N A Peppas
Journal:  Pharm Acta Helv       Date:  1985

8.  Linearization of dissolution rate curves by the Weibull distribution.

Authors:  F Langenbucher
Journal:  J Pharm Pharmacol       Date:  1972-12       Impact factor: 3.765

9.  Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms.

Authors:  M Gibaldi; S Feldman
Journal:  J Pharm Sci       Date:  1967-10       Impact factor: 3.534

Review 10.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

View more
  26 in total

Review 1.  Floating drug delivery systems: a review.

Authors:  Shweta Arora; Javed Ali; Alka Ahuja; Roop K Khar; Sanjula Baboota
Journal:  AAPS PharmSciTech       Date:  2005-10-19       Impact factor: 3.246

2.  Risk-based approach for systematic development of gastroretentive drug delivery system.

Authors:  A G Mirani; S P Patankar; V J Kadam
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

3.  Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.

Authors:  Furquan Nazimuddin Khan; Mohamed Hassan G Dehghan
Journal:  AAPS PharmSciTech       Date:  2011-08-31       Impact factor: 3.246

4.  Formulation of a dry powder influenza vaccine for nasal delivery.

Authors:  Robert J Garmise; Kevin Mar; Timothy M Crowder; C Robin Hwang; Matthew Ferriter; Juan Huang; John A Mikszta; Vincent J Sullivan; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2006-03-10       Impact factor: 3.246

5.  Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.

Authors:  Anand Patel; Moin Modasiya; Dushyant Shah; Vishnu Patel
Journal:  AAPS PharmSciTech       Date:  2009-03-19       Impact factor: 3.246

6.  Evaluation of polyethylene oxide compacts as gastroretentive delivery systems.

Authors:  Ravichandran Mahalingam; Bhaskara Jasti; Raj Birudaraj; Dimitrios Stefanidis; Robert Killion; Tom Alfredson; Pratap Anne; Xiaoling Li
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

7.  Formulation and optimization of sustained release tablets of venlafaxine resinates using response surface methodology.

Authors:  Ashwini R Madgulkar; M R Bhalekar; V J Kolhe; Y D Kenjale
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

8.  Floating matrix dosage form for propranolol hydrochloride based on gas formation technique: development and in vitro evaluation.

Authors:  Kiran Chaturvedi; S Umadevi; Subhash Vaghani
Journal:  Sci Pharm       Date:  2010-09-26

9.  Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.

Authors:  Manoj N Gambhire; Kshitij W Ambade; Sushma D Kurmi; Vilasrao J Kadam; Kisan R Jadhav
Journal:  AAPS PharmSciTech       Date:  2007-09-07       Impact factor: 3.246

10.  Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design.

Authors:  Manvendra S Chauhan; Anil Kumar; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2012-10-27       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.